Cargando…
Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn’s disease
AIM: To investigate genetic factors that might help define which Crohn’s disease (CD) patients are likely to benefit from anti-tumor necrosis factor (TNF) therapy. METHODS: This was a prospective cohort study. Patients were recruited from a university digestive disease practice database. We included...
Autores principales: | Netz, Uri, Carter, Jane Victoria, Eichenberger, Maurice Robert, Dryden, Gerald Wayne, Pan, Jianmin, Rai, Shesh Nath, Galandiuk, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526766/ https://www.ncbi.nlm.nih.gov/pubmed/28785150 http://dx.doi.org/10.3748/wjg.v23.i27.4958 |
Ejemplares similares
-
Plasma microRNA Profile Differentiates Crohn’s Colitis From Ulcerative
Colitis
por: Netz, Uri, et al.
Publicado: (2018) -
Statistical Issues and Group Classification in Plasma MicroRNA Studies With Data Application
por: Rai, Shesh N, et al.
Publicado: (2020) -
Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn’s disease
por: Alfaro, Ignacio, et al.
Publicado: (2019) -
Circulating plasma microRNAs in colorectal neoplasia: A pilot study in assessing response to therapy
por: O'Brien, Stephen J, et al.
Publicado: (2020) -
Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population
por: Kanaan, Ziad M, et al.
Publicado: (2012)